MEI Price To Sales Ratio from 2010 to 2025
| LITS Stock | 1.95 0.13 6.25% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 0.53 | Current Value 0.65 | Quarterly Volatility 0.06867245 |
Check MEI Pharma, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma,'s main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.9 M or Interest Income of 1.9 M, as well as many indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.31 or PTB Ratio of 0.71. MEI financial statements analysis is a perfect complement when working with MEI Pharma, Valuation or Volatility modules.
MEI | Price To Sales Ratio | Build AI portfolio with MEI Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MEI Stock Analysis
When running MEI Pharma,'s price analysis, check to measure MEI Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma, is operating at the current time. Most of MEI Pharma,'s value examination focuses on studying past and present price action to predict the probability of MEI Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma,'s price. Additionally, you may evaluate how the addition of MEI Pharma, to your portfolios can decrease your overall portfolio volatility.